Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NeuroPace (NPCE) Raw Materials (2020 - 2025)

NeuroPace has reported Raw Materials over the past 6 years, most recently at $6.2 million for Q4 2025.

  • Quarterly results put Raw Materials at $6.2 million for Q4 2025, up 60.36% from a year ago — trailing twelve months through Dec 2025 was $6.2 million (up 60.36% YoY), and the annual figure for FY2025 was $6.2 million, up 60.36%.
  • Raw Materials for Q4 2025 was $6.2 million at NeuroPace, down from $6.4 million in the prior quarter.
  • Over the last five years, Raw Materials for NPCE hit a ceiling of $6.4 million in Q3 2025 and a floor of $1.6 million in Q3 2021.
  • Median Raw Materials over the past 5 years was $3.4 million (2023), compared with a mean of $3.6 million.
  • Biggest five-year swings in Raw Materials: soared 99.17% in 2023 and later decreased 16.0% in 2024.
  • NeuroPace's Raw Materials stood at $2.2 million in 2021, then rose by 26.25% to $2.8 million in 2022, then soared by 45.14% to $4.1 million in 2023, then dropped by 5.33% to $3.9 million in 2024, then soared by 60.36% to $6.2 million in 2025.
  • The last three reported values for Raw Materials were $6.2 million (Q4 2025), $6.4 million (Q3 2025), and $6.3 million (Q2 2025) per Business Quant data.